Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Change in Accured Expenses (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Change in Accured Expenses for 9 consecutive years, with -$7.9 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 78.26% year-over-year to -$7.9 million; the TTM value through Mar 2026 reached $23.1 million, down 18.39%, while the annual FY2025 figure was -$5.2 million, 119.79% down from the prior year.
  • Change in Accured Expenses hit -$7.9 million in Q1 2026 for Select Medical Holdings, down from $33.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $91.5 million in Q2 2024 and bottomed at -$39.5 million in Q4 2022.
  • Average Change in Accured Expenses over 5 years is $6.5 million, with a median of -$3.3 million recorded in 2025.
  • Year-over-year, Change in Accured Expenses plummeted 1272.8% in 2024 and then soared 354.76% in 2025.
  • Select Medical Holdings' Change in Accured Expenses stood at -$39.5 million in 2022, then skyrocketed by 259.71% to $63.1 million in 2023, then plummeted by 120.62% to -$13.0 million in 2024, then skyrocketed by 354.76% to $33.1 million in 2025, then plummeted by 123.74% to -$7.9 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$7.9 million, $33.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.